Bristol-Myers Squibb Co (BMY), which is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis, is one of the stocks in my portfolio. Their annual meeting is coming up on 5/5/2015. ProxyDemocracy.org had the votes of four funds when I checked and voted on 4/30/2015. I voted with management 46% of […]
